Hemodynamic performance of the Medtronic Mosaic and Perimount Magna aortic bioprostheses: Five-year results of a prospectively randomized study

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 6, 2011, Pages 844-852

  Dalmau, María José ^a   González Santos, José María ^a   Blázquez, José Antonio ^a   Sastre, José Alfonso ^a   López Rodríguez, Javier ^a   Bueno, María ^a   Castaño, Mario ^a   Arribas, Antonio ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Aortic valve replacement; Biological prosthesis; Hemodynamic performance; Left ventricular mass index

Indexed keywords

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOPROSTHESIS; ECHOCARDIOGRAPHY, DOPPLER; EPIDEMIOLOGIC METHODS; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; PROSTHESIS DESIGN; TREATMENT OUTCOME;

EID: 79955625090     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.11.015     Document Type: Article

References (25)

1. Pibarot P., Dumesnil J.G. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000, 36:1131-1141.
2. Rao V., Jamieson W.R., Ivanov J., Armstrong S., David T.E. Prosthesis-patient mismatch affects survival after aortic valve replacement. Circulation 2000, 102(19 Suppl. 13):III-5-III-9.
3. Pibarot P., Dumesnil J.G., Lemieux M., Cartier P., Metras J., Durand L.G. Impact of prosthesis-patient mismatch on hemodynamic and symptomatic status, morbidity and mortality after aortic valve replacement with a bioprosthetic heart valve. J Heart Valve Dis 1998, 7:211-218.
4. Blais C., Dumesnil J.G., Baillot R., Simard S., Doyle D., Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 2003, 108:983-988.
5. Fuster R.G., Montero Argudo J.A., Albarova O.G., Sos F.H., Lopez S.C., Codoner M.B., Buendia Minano J.A., Albarran I.R. Patient-prosthesis mismatch in aortic valve replacement: really tolerable?. Eur J Cardiothorac Surg 2005, 27:441-449.
6. Seitelberger R., Bialy J., Gottardi R., Seebacher G., Moidl R., Mittelbock M., Simon P., Wolner E. Relation between size of prosthesis and valve gradient: comparison of two aortic bioprosthesis. Eur J Cardiothorac Surg 2004, 25:358-363.
7. Tasca G., Brunelli F., Cirillo M., DallaTomba M., Mhagna Z., Troise G., Quaini E. Impact of valve prosthesis-patient mismatch on left ventricular mass regression following aortic valve replacement. Ann Thorac Surg 2005, 79:505-510.
8. Riess F.C., Cramer E., Hansen L., Schiffelers S., Wahl G., Wallrath J., Winkel S., Kremer P. Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years. Eur J Cardiothorac Surg 2010, 37(1):145-153.
9. Dalmau M.J., Maríagonzález-Santos J., López-Rodríguez J., Bueno M., Arribas A. The Carpentier-Edwards Perimount Magna aortic xenograft: a new design with an improved hemodynamic performance. Interact Cardiovasc Thorac Surg 2006, 5(3):263-267.
10. Banbury M.K., Cosgrove D.M., Thomas J.D., Blackstone E.H., Rajeswaran J., Okies E., Frater R.M. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2002, 73:1460-1465.
11. Christakis G.T., Buth K.J., Goldman B.S., Fremes S.E., Rao V., Cohen G., Borger M.A., Weisel R.D. Inaccurate and misleading valve sizing: a proposed standard for valve size nomenclature. Ann Thorac Surg 1998, 66(4):1198-1203.
12. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
13. Del Rizzo D.F., Abdoh A., Cartier P., Doty D.B., Westaby S. Factors affecting left ventricular mass regression after aortic valve replacement with stentless valves. Semin Thorac Cardiovasc Surg 1999, 11:114-120.
14. Jamieson W.E.R., Janusz M.T., MacNab J., Henderson C. Hemodynamic comparison of second- and third-generation stented bioprostheses in aortic valve replacement. Ann Thorac Surg 2001, 71:S282-S284.
15. Suri R.M., Zehr K.J., Sundt T.M., Dearani J.A., Daly R.C., Oh J.K., Schaff H.V. Left ventricular mass regression after porcine versus bovine aortic valve replacement: a randomized comparison. Ann Thorac Surg 2009, 88(4):1232-1237.
16. Chambers J.B., Rajani R., Parkin D., Rimington H.M., Blauth C.I., Venn G.E., Young C.P., Roxburgh J.C. Bovine pericardial versus porcine stented replacement aortic valves: early results of a randomized comparison of the Perimount and the Mosaic valves. J Thorac Cardiovasc Surg 2008, 136(5):1142-1148.
17. Ruzicka D.J., Hettich I., Hutter A., Bleiziffer S., Badiu C.C., Bauernschmitt R., Lange R., Eichinger W.B. The complete supraannular concept: in vivo hemodynamics of bovine and porcine aortic bioprostheses. Circulation 2009, 120(September (11 Suppl.)):S139-S145.
18. Dalmau M.J., María González-Santos J., López-Rodríguez J., Bueno M., Arribas A., Nieto F. One year hemodynamic performance of the Perimount Magna pericardial xenograft and the Medtronic Mosaic bioprosthesis in the aortic position: a prospective randomized study. Interact Cardiovasc Thorac Surg 2007, 6(3):345-349.
19. Wagner I.M., Eichinger W.B., Bleiziffer S., Botzenhardt F., Gebauer I., Guenzinger R., Bauernschmitt R., Lange R. Influence of completely supra-annular placement of bioprostheses on exercise hemodynamics in patients with a small aortic annulus. J Thorac Cardiovasc Surg 2007, 133(5):1234-1241.
20. Pibarot P., Dumesnil J.G., Cartier P.C., Métras J., Lemieux M.D. Patient-prosthesis mismatch can be predicted at the time of operation. Ann Thorac Surg 2001, 71:S265-S268.
21. Flameng W., Meuris B., Herijgers P., Herregods M.C. Prosthesis-patient mismatch is not clinically relevant in aortic valve replacement using the Carpertier-Edwards Perimount valve. Ann Thorac Surg 2006, 82:530-536.
22. Krayenbuehl H., Hess O.M., Monrad S., Schneider J., Mall G., Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and later after aortic valve replacement. Circulation 1989, 79:744-755.
23. Hanayama N., Christakis G.T., Mallidi H.R., Joyner C.D., Fremes S.E., Morgan C.D., Mitoff P.R., Goldman B.S. Patient prosthesis mismatch is rare after aortic valve replacement: valve size may be irrelevant. Ann Thorac Surg 2002, 73:1822-1829.
24. Dumesnil J.G., Yoganathan A.P. Valve prosthesis hemodynamics and the problem of high transprosthetic pressure gradients. Eur J Cardiothorac Surg 1992, 6:S34-S38.
25. Dellgren G., Eriksson M.J., Blange I., Brodin L.A., Radegran K., Sylven C. Aongiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patient undergoing operation for aortic stenosis. Am J Cardiol 1999, 84:909-913.